Highlighted Paper selected by Editor-in-Chief : The Truncated Isoform of the Receptor Tyrosine Kinase ALK Generated by Alternative Transcription Initiation (ALK[ATI]) Induces Chromatin Structural Changes in the Nucleus in a Kinase Activity-Dependent Manner
-
- Takakura Yuki
- Laboratory of Molecular Cell Biology, Graduate School of Pharmaceutical Sciences, Chiba University
-
- Yamaguchi Noritaka
- Laboratory of Molecular Cell Biology, Graduate School of Pharmaceutical Sciences, Chiba University
-
- Honda Takuya
- Laboratory of Molecular Cell Biology, Graduate School of Pharmaceutical Sciences, Chiba University
-
- Morii Mariko
- Laboratory of Molecular Cell Biology, Graduate School of Pharmaceutical Sciences, Chiba University
-
- Yuki Ryuzaburo
- Laboratory of Molecular Cell Biology, Graduate School of Pharmaceutical Sciences, Chiba University
-
- Nakayama Yuji
- Department of Biochemistry and Molecular Biology, Kyoto Pharmaceutical University
-
- Yamaguchi Naoto
- Laboratory of Molecular Cell Biology, Graduate School of Pharmaceutical Sciences, Chiba University
書誌事項
- タイトル別名
-
- The Truncated Isoform of the Receptor Tyrosine Kinase ALK Generated by Alternative Transcription Initiation (ALK<sup>ATI</sup>) Induces Chromatin Structural Changes in the Nucleus in a Kinase Activity-Dependent Manner
- The truncated isoform of the receptor tyrosine kinase ALK generated by alternative transcription initiation (ATLATI) induces chromatin structural changes in the nucleus in a kinase activity-dependent manner
この論文をさがす
抄録
<p>Anaplastic lymphoma kinase (ALK) is a receptor-type tyrosine kinase that promotes cell growth upon stimulation with ligands such as midkine and pleiotrophin. Recently, a truncated isoform of ALK was identified in a variety of tumors. This isoform is expressed from a novel ALK transcript initiated from a de novo alternative transcription initiation (ATI) site in ALK intron 19 (referred to as ALKATI). ALKATI, which consists of only the intracellular kinase domain, localizes to the nucleus as well as the cytoplasm. However, its nuclear role is unknown. In this study, we determined that ALKATI promoted chromatin structural changes in the nucleus in a kinase activity-dependent manner. We found that expression of ALKATI increased the level of the heterochromatin marker Lys9 tri-methylated histone H3. In addition, we demonstrated that ALKATI phosphorylated the nuclear protein A-kinase anchoring protein 8 (AKAP8) and altered its subcellular localization from the insoluble fraction to the soluble fraction. These results suggest that ALKATI induces chromatin structural changes and heterochromatinization through phosphorylation of AKAP8 in the nucleus.</p>
収録刊行物
-
- Biological & Pharmaceutical Bulletin
-
Biological & Pharmaceutical Bulletin 40 (11), 1968-1975, 2017
公益社団法人 日本薬学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390282679611155200
-
- NII論文ID
- 130006191980
-
- NII書誌ID
- AA10885497
-
- ISSN
- 13475215
- 09186158
-
- NDL書誌ID
- 028602370
-
- PubMed
- 29093346
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
- KAKEN
-
- 抄録ライセンスフラグ
- 使用不可